FDA approves first-ever mRNA flu vaccine for millions of older Americans

The FDA has approved the nation's archetypal flu vaccine made with mRNA technology, the manufacturer, Moderna, announced connected Thursday.

The vaccine, which is based connected the aforesaid messenger RNA level utilized successful COVID-19 shots, has been afloat approved for adults ages 50-64 up of the 2026-2027 flu season.

For adults 65 and older, the vaccine received accelerated approval, which allows the vaccine to beryllium utilized portion Moderna completes an further survey to corroborate its effectiveness successful seniors.

PANCREATIC CANCER VACCINE SHOWS PROMISE IN FIRST HUMAN TRIAL, PREVENTING DISEASE IN HIGH-RISK PATIENTS

Experts accidental mRNA vaccines tin beryllium updated much rapidly to support against changes successful circulating flu strains.

The support was based connected a signifier 3 objective proceedings including astir 40,000 participants, successful which the caller vaccine was recovered to effect a 27% simplification successful flu cases compared to a modular flu vaccine.

The FDA has approved the nation's archetypal flu vaccine made with mRNA technology, the manufacturer, Moderna, announced connected Thursday. (iStock)

No large information concerns were identified successful the trial, according to the announcement.

It was recovered to person much short-term broadside effects than accepted flu shots – including limb pain, fatigue, headache and fever – though these were noted to beryllium mostly mild and temporary.

CLICK HERE FOR MORE HEALTH STORIES

"This is not a cosmopolitan vaccine, but is geared for accelerated turnaround erstwhile the yearly strains person been identified," said Dr. Marc Siegel, Fox News elder aesculapian analyst.

"It’s akin to the COVID vaccine and was recovered to beryllium 25% to 30% much effectual than the existent flu vaccine," helium added. "It’s geared to support the elderly."

Doctors uncover what you should bash earlier getting your flu changeable this play to maximize effectiveness  (iStock)

Older adults look the biggest hazard of terrible influenza. During the 2024-2025 season, radical 65 and older accounted for 57% of flu-related hospitalizations and 71% of deaths, according to the Centers for Disease Control and Prevention.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

An estimated 51 cardinal Americans contracted the flu during the 2024-2025 season, with the microorganism linked to astir 710,000 hospitalizations and 45,000 deaths, per the supra source.

Looking ahead, the support could pave the mode for operation vaccines that support against aggregate respiratory viruses astatine once, according to Moderna. (REUTERS/Brian Snyder)

Earlier this year, the caller mRNA vaccine faced a regulatory setback erstwhile the FDA initially refused to reappraisal Moderna's application, citing concerns astir the plan of its objective trial, the Associated Press reported.

Moderna disputed the decision, and the FDA aboriginal agreed to determination guardant with the review.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

In June, an autarkic FDA advisory committee agreed that the vaccine's benefits outweighed its risks, paving the mode for its approval.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Looking ahead, the support could pave the mode for operation vaccines that support against aggregate respiratory viruses astatine once, according to Moderna.

The institution said it is pursuing a combined flu/COVID vaccine, with the extremity of giving radical 1 seasonal shot.